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ABSTRACT
Objective To measure the short term impact on hospital
admissions for myocardial infarction of the introduction
of smoke-free legislation in England on 1 July 2007.
Design An interrupted time series design with routinely
collected hospital episode statistics data. Analysis of
admissions from July 2002 to September 2008 (providing
five years’ data frombefore the legislation and 15months’
data from after) using segmented Poisson regression.
Setting England.
Population All patients aged 18 or older living in England
with an emergency admission coded with a primary
diagnosis of myocardial infarction.
Main outcome measuresWeekly number of completed
hospital admissions.
Results After adjustment for secular and seasonal trends
and variation in population size, there was a small but
significant reduction in the number of emergency
admissions for myocardial infarction after the
implementation of smoke-free legislation (−2.4%, 95%
confidence interval −4.06% to −0.66%, P=0.007). This
equates to 1200 fewer emergency admissions for
myocardial infarction (1600 including readmissions) in
the first year after legislation. The reduction in admissions
was significant in men (3.1%, P=0.001) and women
(3.8%, P=0.007) aged 60 and over, and men (3.5%,
P<0.01) but not women (2.5% P=0.38) aged under 60.
Conclusion This study adds to a growing body of evidence
that smoke-free legislation leads to reductions in
myocardial infarctions. It builds on previous work by
showing that such declines are observed even when
underlying reductions in admissions and potential
confounders are controlled for. The considerably smaller
decline in admissions observed in England compared
with many other jurisdictions probably reflects aspects of
the study design and the relatively low levels of exposure
to secondhand smoke in England before the legislation.
INTRODUCTION
Numerous studies, including sixmeta-analyses,1-6 have
shown that passive smoking increases the risk of cor-
onary heart disease.7 Early studies estimated the
increased risk at about 30%, but use of marriage to a
smoker as a proxy for exposure underestimated
exposure.5 Recent evidence, based on more accurate
biological markers of exposure, suggests the risk could
be increased by as much as 60%, similar to that
observed in light active smokers.8 Although this risk
might seem disproportionate, it is consistent with sub-
stantial epidemiological and laboratory evidence that
the risk of coronary heart disease increases rapidly at
low levels of exposure to tobacco smoke.9 10 Even small
exposures have been shown to rapidly increase platelet
aggregation and alter endothelial function (with such
changes observed within 30 minutes of exposure) and
cause other arterial and haemodynamic changes that
can increase the risk of coronary heart disease and trig-
ger acute coronary events.7 9 11-13 Measures that reduce
exposure to secondhand smoke, such as smoke-free
legislation, are therefore likely to reduce the incidence
of acute coronary events, including myocardial infarc-
tion, with almost immediate effect.12
Smoke-free legislation has now been introduced in
several jurisdictions, and a growing body of evidence
links the introduction of this legislation with a reduc-
tion in hospital admissions for myocardial infarction
and other acute coronary events.14-17 The largest
impacts have been reported in smaller studies in the
United States,18-20 with reported reductions in the
range of 27-40%, while larger studies have reported
more modest reductions: 8% in the state of New
York,21 13% in four Italian regions,22 and 17% in
Scotland.23 Only two studies in New Zealand24 and
Piedmont, Italy,25 found no reduction in overall admis-
sions for myocardial infarction, although the Italian
study found an 11% decline in those aged under 60.
There is some uncertainty around the extent to
which some of these studies have effectively accounted
for other factors thatmight influence patterns of admis-
sions for myocardial infarction. Firstly, admissions for
coronary heart disease have been declining across
Europe,26-30 the US,31 and Canada,32 and failure to
account for this might lead to an overestimation of
impacts. Secondly, other factors such as season, flu,
and temperature have all been shown to influence the
incidence of myocardial infarction with, for example,
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peak admission rates in winter, in spring, and over the
Christmas break, and seen in association with high flu
rates and low temperatures.33-36 Most studies
accounted for seasonal differences when estimating
impacts of smoke-free legislation on coronary heart
disease, either by comparing the same months in a
before-after study design20 23 25 37 38 or including a pre-
dictor for time of year in a regression model.18 21 24
Few studies, however, fully accounted for underlying
trends in admissions.21 22 24 39 This is important as trends
seem to differ by age group,40 41 and only one study
comprehensively adjusted for other risk factors,
including temperature and flu rates.39
We addressed all these issues by examining the
impact of legislation on hospital admissions for myo-
cardial infarction in England, where all enclosedwork-
places and public places, with a few exceptions,
became smoke-free on 1 July 2007.
METHODS
Evaluating impacts of smoke-free England
Data
Hospital episode statistics (HES) data provide routi-
nely collected information on all patients who receive
care from the National Health Service (NHS) in
England.42 Each completed record comprises a “fin-
ished consultant episode,” a period of time a patient
spends under the care of one NHS consultant. We
extracted data for all finished emergency admission
episodes in those aged 18 and over living in England,
with an admission date between 1 July 2002 (five years
before the legislation) and 30 September 2008
(15 months after the legislation) and a primary diagno-
sis of ICD-10 (international classification of disease,
10th revision) code I21 (myocardial infarction).43 We
retained only the first episode (known as the admission
episode) of a patient’s stay in hospital because these
were more likely to reflect myocardial infarction
events that had occurred outside of hospital rather
than those occurring as complications of hospital treat-
ment. In line with the ICD-10 code I21 definition of
“myocardial infarction specified as acute or with a sta-
ted duration of 4 weeks (28 days) or less from onset”43
and to avoid duplicate admissions for the same event,
we excluded any repeat admissions within a 28 day
period. Records missing data on age or sex were
excluded from the analysis (less than 0.1% of records).
Statistical analyses
Using an interrupted time series design, we developed
a segmented Poisson regression model44 to test the
hypothesis that there was a change in the number of
emergency admissions for myocardial infarction
immediately after the introduction of smoke-free legis-
lation (that is, fromMonday 2 July 2007 onwards). The
response variable was the weekly number of admis-
sions, with variation in week length (week 52 was
eight days in a non-leap year and nine in a leap year)
accounted for by including log number of days as a
predictor in the model. The impact of smoke-free leg-
islation, defined as a change in the rate of admissions
for myocardial infarction after the legislation, was
assessed by including a binary predictor variable in
the model with a value of 1 assigned to myocardial
infarction events occurring from week 27 of that year
(that is, from 2 July 2007 onwards) and 0 before.
An initial exploration of the form of the long term
time trend suggested that a linear assumption was
appropriate, so we used a linear predictor for time to
quantify the underlying downwards trend in admis-
sions. We used 1 July 2002 as the start date, providing
five years of pre-legislative data. Various additional
predictors were then included in the model to account
for variation in admissions for myocardial infarction
attributable to factors other than the implementation
of smoke-free legislation.33-36 To model the temporal
fluctuations, we used temperature, flu, week of year,
and an indicator variable for the Christmas holidays
(1 if it is the first or last week in the year and 0 other-
wise).Weekly temperatures were themean of the daily
mean surface air temperatures obtained from the Cen-
tral England Temperature data series.45 46 As prelimin-
ary exploration of the data suggested that the effects of
temperature might be delayed,47 we considered two
predictors: temperature in the sameweek as the admis-
sion and temperature in the previous week.Weekly flu
rates for England and Wales were obtained from the
Royal College of General Practitioners’ research and
surveillance centre, which collects data on consulta-
tions for flu-like illnesses from about 100 general prac-
tice surgeries, and log transformed before analysis.
Temperature and flu rates were considered as linear
terms in the model while week of year was included
as a cyclic cubic spline to capture any additional seaso-
nal patterns that might be non-linear.
The population estimate for England was included
as an offset variable—namely, a predictor variablewith
a regression coefficient fixed at 1. This ensures there is
a one to one relation between the population size and
the number of admissions. Weekly population esti-
mates were obtained by linearly interpolating mid-
year population estimates for 2002 to 2007 and popu-
lation projections for 2008 and 2009 provided by the
UK’s Office for National Statistics.
Models were fitted inR.8.1 using the gamand gamm
functions from the librarymgcv.48 After adjustment for
smoke-free legislation, number of days, and popula-
tion size, we considered the other predictor variables
in a backwards selection procedure to identify the best
model using themgcv library’s unbiased risk estimator
(UBRE), an approximation to Akaikes Information
Criterion,49 to compare candidate models. Models
with a lower unbiased risk estimator are preferred.48
The suitability of the selected statistical model was
assessed with plots of residuals, including an assess-
ment of any remaining serial correlation in the resi-
duals using autocorrelation plots. When necessary,
presence of short term autocorrelation was modelled
by applying a first order autoregressive AR(1) struc-
ture to the residuals.
To assess differences in the impact of smoke-free leg-
islation among population subgroups, we stratified the
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data by age (<60, ≥60) and sex and performed separate
analyses on each group. We also examined whether
there was an increase or decrease in the slope of the
trend after the legislation, compared with pre-legisla-
tive trends, by adding an interaction term between the
binary predictor for smoke-free legislation and the lin-
ear predictor for time to themodels. To provide further
support for the findings we refitted the final models
using 16 false dates for smoke-free legislation ranging
from January 2005 to January 2007.
Predicting the number of events prevented
We used the final Poisson regression model to predict
the number of emergency admissions for myocardial
infarction that were prevented as a result of smoke-free
legislation in the first year of implementation. To esti-
mate thenumberof averted eventsNewe subtracted the
regression based prediction of the number of events
from 1 July 2007 to 30 June 2008 (Nw) from the pre-
dicted number of events without the influence of the
legislation (Now). If β is the estimated regression coeffi-
cient for the smoke-free legislation predictor from the
final Poisson regressionmodel,Now is equivalent toNw/
exp(β). The total number of emergency admissions
averted will be slightly higher than Ne because some
of the events result in multiple emergency readmis-
sions to hospital within 28 days, and we excluded
these readmissions from the main analysis. Therefore,
to predict the total number of emergency admissions
prevented we repeated the statistical analysis on a data-
set that included readmissions.
RESULTS
Between2000 and2008 therewas anotable decrease in
the number of emergency admissions for myocardial
infarction, a decrease that seems to have accelerated
from around 2002 and was greater in older than
younger age groups (figs 1 and 2). The seasonal pattern
observed was consistent with that reported
elsewhere,33-36 with a peak in admissions over Christ-
mas and early spring, higher rates of admission over
winter, and lower rates in summer (fig 3). Indeed the
decline each summer was of a similar order of magni-
tude to the secular decline seen over the six year period
studied. Most admissions occurred in men and those
aged over 60 with relatively few events in women aged
under 60 (table 1).
Of the predictor variables entered in the initial mod-
els, only flu, whichwas highly correlatedwith tempera-
ture, was dropped from all models. Temperature was
dropped from the models for those aged under 60 and
Christmas holidays from the model for men aged
under 60 (table 2).We added first order autoregressive
AR(1) terms to the final models for all people and for
women aged 60 and over to allow for short term auto-
correlation.
After the implementation of smoke-free legislation,
there was a significant drop of 2.4% (P=0.007) in the
number of emergency admissions for myocardial
infarction (table 2). This implies that just over 1200
emergency admissions for myocardial infarction were
prevented over a 12monthperiod.Given that an initial
myocardial infarction might result in several subse-
quent emergency admissions to hospital, this equates
to around 1600 fewer emergency admissions. The sub-
group analyses indicated that the legislation had an
impact in men and women aged 60 and over, with a
reduction of 3.07% (P=0.001) and 3.82% (P=0.007),
respectively. Men aged under 60 also showed a signifi-
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Fig 1 | Trends in weekly number of emergency admissions for
myocardial infarction (average daily count) from January 2000
to September 2008 by age and sex. Note different ranges on y
axis
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cant drop in admissions of 3.46% (P<0.01), but the
regression analysis gave no indication of a decline in
younger women (2.46%, P=0.38). There was no evi-
dence of a change in the slope of the trend line after
the legislation.
By refitting themodel with false dates for smoke-free
legislation, we found that none of the false dates led to a
significant impact in the population as a whole or in
men of any age. In women aged over 60, however,
modelling with all but one of the false dates from the
end of 2005 to 2007 yielded significant results.
DISCUSSION
Hospital admissions for myocardial infarction
dropped significantly after the introduction of smoke-
free legislation in England. After adjustment for the
pre-existing decline in admissions, trends in popula-
tion size, and seasonal variation in admissions, we
found a 2.4% drop in the number of emergency admis-
sions for myocardial infarction after the legislation.
This equates to 1200 fewer emergency admissions for
myocardial infarction in the first year after the law
came into effect (1600 including readmissions).
We identified a smaller reduction than other studies.
We believe there are two main explanations for this.
Firstly, exposure to secondhand smoke immediately
before legislation was substantially lower in England
than in other jurisdictions because of marked declines
in population exposure in advance of the legislation.50
Secondly, our studymethods differed, with potentially
better control of confounding.
Exposure before legislation
Smoke-free legislation in England was introduced at a
time when many public places and workplaces were
already smoke-free. In the year before implementa-
tion, a nationally representative survey (ONS Omni-
bus Survey) indicated that 55% of employed adults in
England alreadyworked in a smoke-free environment.
In addition, some bars and restaurants, the venues
most affected by the legislation, went smoke-free
before 1 July. Therefore, despite high compliance
with the legislation,51 the decline in smoke exposure
and the resulting health benefits of smoke-free legisla-
tion that occurred immediately after the implementa-
tion of legislation are likely to have been less marked
than those observed elsewhere,making themharder to
detect in a study such as this. A similar issue was noted
in New York, where various pre-existing smoking
restrictions were in place.21
Levels of exposure to secondhand smoke were
around 50% lower in England than in Scotland just
before implementation of legislation in each country,
whether measured by concentrations of particulate
matter in bars50 or cotinine concentrations (a biochem-
ical marker of smoke exposure) in non-smoking bar
workers50 and the general public.52 53 While this might
be partly explained by the introduction of legislation in
England in summer and in Scotland in winter, the fact
that the collection periods for the populationdata over-
lap in the two jurisdictions and that greater absolute
declines in exposure were seen in Scotland suggest
this cannot be the whole explanation.
Data on cotinine concentrations from population
surveys indicates that population exposure to second-
hand smoke in England has declined markedly since
the mid-1990s. From 1993 to 2003 cotinine concentra-
tions almost halved in non-smoking adults living with
non-smoking partners and declined by a third in those
living with smoking partners.54 In children, for whom
more recent data on cotinine are available, there has
been a 59% decline in exposure between 1996 and
2006, with the largest annual decline in the year imme-
diately before smoke-free legislation.55 If levels of
exposure in adults have continued to decline, in line
with those of children, some of the underlying decline
in admissions to hospital for myocardial infarction
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Fig 2 | Trends in overall weekly number of emergency
admissions for myocardial infarction (average daily count)
from January 2000 to September 2008. Note, weekly numbers
of admissions are sum of four graphs in figure 1
Table 1 | Number of emergency admissions* for myocardial infarction in England overall and by age group
Year beginning 1 July All events
Men Women
<60 ≥60 <60 ≥60
2002 61 498 11 704 26 701 2746 20 347
2003 60 680 11 676 25 841 2718 20 445
2004 58 803 11 448 24 996 2635 19 724
2005 55 752 10 952 23 679 2627 18 494
2006 53 964 11 075 22 781 2636 17 472
2007 51 664 10 457 21 824 2536 16 847
*Only admissions that met study’s inclusion criteria.
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before July 2007 is probably due to reductions in popu-
lation exposure to secondhand smoke. Moreover,
given that some of the decline in exposure is probably
attributable to smoke-free legislation either indirectly
(for example, through changes in behaviour triggered
by growing public debates over secondhand smoke) or
directly (public venues going smoke-free in advance of
1 July), studies such as this, designed to detect changes
immediately after implementation, will underestimate
impacts.
Differences in methods
The second explanation for the more modest decline
found in our study relates to differences in methods.
Several of the earlier studies used a “before and after”
study design, and, although some used geographical
controls, they might have been unable to fully account
for underlying trends in admissions for myocardial
infarction. Given the marked decline observed in
admissions from 2002 onwards in our data, consistent
with similar declines observed elsewhere,26-32 this
might account for the greater reductions seen in such
studies. Moreover, even if the before and after periods
of these studies spanned the same months, bias from
unseasonal weather patterns and fluctuations in the
prevalence of other factors known to influence rates
of coronary heart disease might have contributed to
the changes observed. By accounting for the underly-
ing decline in emergency admissions for myocardial
infarction, seasonal patterns, and other risk factors
(which few other studies have controlled for)39 we will
produce a more conservative assessment of the contri-
bution of smoke-free public places to reducing the
number of emergency admissions. Although this
might more accurately reflect the immediate impact
of the implementation of the smoke-free law in Eng-
land, for the reasons identified above, our estimate
will miss the contribution of the legislation to the pre-
legislative declines in exposure to secondhand smoke
and will thus underestimate its full impact.
Validity and age, sex differences
Although our reported impacts were significant
(P<0.01 in all but women aged under 60), the confi-
dence intervals were close to the null effect. There is,
however, substantial reason for believing the decline in
admissions is valid. It is biologically plausible, as out-
lined above, and robust to the “false dates” analysis in
all but older women (discussed below). Moreover,
when we imputed smoking prevalence and self
reported data on exposure from the Health Survey for
England56 into a mathematical model developed by
Richiardi et al57 to predict the impact of smoke-free
legislation on admissions for myocardial infarction,
the predicted reductions in admissions were between
3.6% and 10.9% in men and 2.4% and 7.2% in women.
Our results are therefore consistent with the lower esti-
mates obtained from the Richiardi model.57
Impacts were observed in men regardless of age,
while in women we found a significant impact only
among those aged 60 or over in whom some of the
“false dates” also led to significant findings, indicating
uncertainty around the impacts in this group.Although
many studies do not examine impacts by sex,18-21 37 the
absence of an impact in women was also seen in
Rome39 and in four other Italian regions.22 Three issues
are worth considering here. Firstly, given that it was
only the false dates during the 18 months before the
Table 2 | Results of Poisson regression analyses to detect association between smoke-free legislation in England and emergency admissions for myocardial
infarction
Final models* All events
Men Women
<60 ≥60 <60 ≥60
% change after smoke-free legislation† (95% CI) −2.37‡ (−4.06 to −0.66) −3.46‡ (−5.99 to −0.85) −3.07‡ (−4.86 to −1.25) −2.46 (−7.62 to 3.00) −3.82‡ (−6.48 to −1.09)
Other predictors kept in analysis:
Time (long term trend) Yes Yes Yes Yes Yes
Temperature§ Yes No Yes No Yes
Flu No No No No No
Christmas holidays Yes No Yes Yes Yes
Week of year Yes Yes Yes Yes Yes
Residuals:
AR(1) model Yes No No No Yes
*All regression models were adjusted for population size, number of days, and smoke-free legislation.
†Calculated by exponentiating estimated regression coefficient for smoke-free legislation predictor.
‡P<0.01.
§In previous week.
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legislation that were significant, this could suggest, in
line with the issues raised above, that exposure to sec-
ondhand smoke was already declining in women and
the false positives might therefore reflect a real, albeit
gradual, reduction in myocardial infarction attributa-
ble to gradual declines in exposure. Secondly, both
pre-legislative levels of, and reductions in, self reported
exposure to secondhand smoke were lower in women
thanmen.56 Thirdly, as a result of their low numbers of
admissions, therewas insufficient power in the analysis
of women aged under 60 to detect the small impacts
observed in men. Power calculations show that drops
between 2-3% can be detected with high power (80%)
in all other population subgroups, but in women aged
under 60, only reductions greater than 7.5% could be
detected with comparable power. As such, we can be
confident only that therewas no reduction greater than
7.5% in this subgroup. Whatever the reasons, the
results in women must clearly be treated with caution.
Limitations
The main weakness of our study, common to most
other studies on this topic,18-22 24 25 37-39 was that we
relied on routine hospital data. Such data do not
include the smoking status of patients, and we were
therefore unable to determine howmuch of the decline
after the legislation was attributable to reduced expo-
sure to secondhand smoke and how much to reduc-
tions in active smoking. This is something we are
currently investigating through analysis of another
dataset.
Furthermore, definitions of and thresholds for diag-
nosing myocardial infarction have changed over
time,58 but the impact of this on routine records of hos-
pital admissions is not fully understood.59 A redefini-
tion of myocardial infarction occurred in 2000,
wherein greater emphasis was placed on the use of spe-
cific biochemical markers (notably troponin).60 This
was predicted to lead to an increase in the number of
diagnosed myocardial infarctions, albeit on a gradual
basis as the availability of troponin assays gradually
increased.59 Although we observed no marked
increase in admissions between 2000 and 2002 nor
from1997 to 2000 (data not shown), we chose to exam-
ine data from 2002 onwards to allow for any change in
diagnostic threshold to take effect. In this way, and by
including a linear predictor for time in our model, we
hoped to capture any gradual change that might have
occurred as best we could.
Reductions in hospital admissions for myocardial
infarction might also be explained by increases in
deaths from myocardial infarction outside hospital.
Studies in Europe that have examined this issue, how-
ever, found a reduction in out of hospital deaths for
coronary events accompanying the corresponding
decline in admissions,23 39 and this is therefore unlikely
to be a concern.
Given that England was the last part of the UK to
implement national smoke-free legislation (Scotland
in March 2006, Wales and Northern Ireland in April
2007), an assessment of the impact compared with a
control population with similar demographics was
not feasible. But even if a control population had
been available, confounding would not have been
completely removed if an unusual event had occurred
in only one population.
Aggregating individual admissions data to the
national level meant we could consider only national
level covariates. This prevented us from including
local level covariates, such as temperature and air pol-
lution, in the model.61 62 Although this is unlikely to be
a key concern for temperature given the high correla-
tion documented between the Central England Tem-
perature data series and the temperature at individual
weather stations,63 it illustrates that residual confound-
ing from unknown factors might remain. Finally, we
were able to explore only the short term impact of
the legislation, and it is possible that the impact on
admissions for myocardial infarctions might vary
over time, with two recent reviews suggesting that
impacts could increase over time.14 15
Strengths
Despite these concerns, we believe our study has sev-
eral strengths and advantages over existing studies.
With apopulationof 49million (2001 census), England
is the largest jurisdiction yet to go smoke-free. By using
a comprehensive national dataset we were therefore
able to provide a study population considerably larger
than those of previous studies, which range from 19
million (New York State),21 through 2-5 million (New
Zealand,24 parts of Italy,22 25 39 and Scotland23), to less
than 200 000 (jurisdictions in US18-20 38 and Canada37)
and thus to offer greater statistical power to detect an
impact in such a short time scale. We estimate that the
smallest reduction detectablewith a power of 0.8, often
considered the desirable level of power, is almost 2%.
This is important because other jurisdictions that, like
England, have partial smoke-free restrictions in place
before comprehensive legislation might be unable to
detect changes this small because of their smaller popu-
lations and thus sample sizes. Furthermore, the robust
segmented Poisson regression analysis, to a greater
extent than most previous studies, was able to mini-
mise confounding by accounting for underlying trends
in population size and admissions for myocardial
infarction and potential confounders such as season,
temperature, flu, and holidays.
We therefore conclude that the implementation of
smoke-free public places is associated with significant
reductions in hospital admissions for myocardial
infarction even in jurisdictions with pre-existing smok-
ing restrictions. Given the large number of myocardial
infarction events per year, even the relatively small
reduction seen in England has important public health
benefits.
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